OCTOBER 2024LIFE SCIENCES REVIEW5CXO INSIGHTSCXO INSIGHTSAccelerating drug development of novel targeted therapies through histology-agnostic oncology clinical trialsBy Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker, Zai Lab23The Future of the Life Sciences IndustryMatthew (Matt) Hewitt, Vice President, CTO Manufacturing Business Division, Charles River Laboratories20Flexibility to Change is the Key to Successful Pharma ProjectsCarrie Lewis, Executive Director, Clinical Program Optimization,Endo International plc17Navigating Leadership and Innovation in RadiologyRyan Garland MHA, AVP- South Region Radiology & Respiratory, Endeavor Health18Three C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientNick Thomson, Vice President Process Chemistry and Technology, Pfizer Inc28APTAMER DEVELOPMENT COMPANY OF THE YEAR 2024Aptagen Labs24G. Thomas Caltagirone,President and CEO
< Page 4 | Page 6 >